INTERMITTENT AORTIC CROSS-CLAMPING PREVENTS CUMULATIVE ADENOSINE-TRIPHOSPHATE DEPLETION, VENTRICULAR-FIBRILLATION, AND DYSFUNCTION (STUNNING) - IS IT PRECONDITIONING
As. Abdelfattah et al., INTERMITTENT AORTIC CROSS-CLAMPING PREVENTS CUMULATIVE ADENOSINE-TRIPHOSPHATE DEPLETION, VENTRICULAR-FIBRILLATION, AND DYSFUNCTION (STUNNING) - IS IT PRECONDITIONING, Journal of thoracic and cardiovascular surgery, 110(2), 1995, pp. 328-339
This study was designed to determine whether intermittent warm aortic
crossclamping induces cumulative myocardial stunning or if the myocard
ium becomes preconditioned after the first episode of ischemia in cani
ne models in vivo. The role of adenosine triphosphate catabolism and s
ubsequent release of purines on reperfusion-mediated postischemic vent
ricular dysfunction and arrhythmias was assessed with the use of selec
tive inhibitors of nucleoside transport, p-nitrobenzylthioinosine (NBM
PR), and a specific adenosine deaminase inhibitor, erythro-9- [2-hydro
xy-3-nonyl] adenine (EHNA). Thirty two anesthetized dogs were instrume
nted to monitor left ventricular contractility, off bypass, by sonomic
rometry. During cardiopulmonary bypass dogs were treated before ischem
ia with either saline solution (control group, n = 8) or EHNA (100 mu
mol/L) and NBMPR (25 mu mol/L) (EHNA/NBMPR group, n = 8). Hearts were
subjected to either 60 minutes of global ischemia and 120 minutes of r
eperfusion (n = 16) or 6 episodes of 10 minutes of global ischemia and
10 minutes of reperfusion, followed by 60 minutes of reperfusion (n =
16). Sixty minutes of sustained ischemia resulted in 80% loss of aden
osine triphosphate and induced reperfusion-mediated ventricular fibril
lation and severe left ventricular dysfunction in the control group. E
HNA/NBMPR treatment augmented myocardial adenosine trapping during isc
hemia, attenuated ventricular fibrillation, and enhanced left ventricu
lar functional recovery, despite similar depletion of adenosine tripho
sphate (80% loss). In the intermittent ischemia experiment, the first
episode of 10 minutes of ischemia and reperfusion caused significant a
denosine triphosphate depletion, ventricular fibrillation, and left ve
ntricular stunning in both control and drug-treated groups. The preval
ence of ventricular fibrillation was greater in the control group than
in the drug-treated group after the first episode of ischemia (p < 0.
05). Adenosine was the major nucleoside accumulated in the myocardium
at the end of 10 minutes of ischemia in the EHNA/NBMPR-treated group (
p < 0.05 versus control). Subsequent episodes of ischemia prevented ve
ntricular fibrillation and did not cause cumulative left ventricular s
tunning in either group. Left ventricular function fully recovered in
the EHNA/NBMPR-treated group after intermittent ischemia, but remained
stunned in the control group. Unlike sustained ischemia, intermittent
ischemia and reperfusion preserved myocardial adenosine triphosphate,
limited purine release, and prevented ventricular fibrillation and cu
mulative stunning. These results suggest that intermittent ischemia an
d reperfusion augmented the endogenous protective mechanism or mechani
sms of ''preconditioning.'' Nucleoside trapping improved functional re
covery after sustained or repetitive ischemia. It is concluded that ad
enosine triphosphate preservation or blockade of nucleoside transport
may play an important role in the activation of endogenous myocardial
protective mechanisms that ''precondition'' against subsequent ischemi
c stress.